TEBALDI, Matteo
 Distribuzione geografica
Continente #
NA - Nord America 2.513
EU - Europa 504
AS - Asia 414
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.435
Nazione #
US - Stati Uniti d'America 2.513
CN - Cina 208
IT - Italia 137
UA - Ucraina 82
TR - Turchia 79
DE - Germania 71
SG - Singapore 69
GB - Regno Unito 60
SE - Svezia 55
FR - Francia 37
FI - Finlandia 29
PL - Polonia 24
ID - Indonesia 22
HK - Hong Kong 10
VN - Vietnam 9
IN - India 5
BE - Belgio 4
IR - Iran 3
KR - Corea 3
AE - Emirati Arabi Uniti 2
BR - Brasile 2
CH - Svizzera 2
BD - Bangladesh 1
CL - Cile 1
CZ - Repubblica Ceca 1
EU - Europa 1
JP - Giappone 1
MD - Moldavia 1
PH - Filippine 1
RU - Federazione Russa 1
TW - Taiwan 1
Totale 3.435
Città #
Fairfield 387
Woodbridge 310
Ashburn 271
Houston 181
Chandler 173
Seattle 132
Wilmington 127
Cambridge 122
Jacksonville 110
Ann Arbor 105
Princeton 61
Beijing 58
Izmir 51
San Diego 47
New York 45
Nanjing 40
Shanghai 39
Singapore 39
Ferrara 38
Milan 30
Warsaw 24
Jakarta 22
Bremen 19
Boardman 17
Nanchang 13
Falls Church 11
Chicago 10
Hong Kong 10
Dong Ket 9
Augusta 8
Jiaxing 8
Lappeenranta 8
Shenyang 8
Tianjin 8
Hebei 7
London 7
Norwalk 7
Washington 7
Bologna 6
Mountain View 6
Changsha 5
Los Angeles 5
Ningbo 5
Addison 4
Auburn Hills 4
Brussels 4
Des Moines 4
Indiana 4
Kunming 4
Redmond 4
Redwood City 4
Duncan 3
Frankfurt am Main 3
Helsinki 3
Hounslow 3
Orange 3
San Mateo 3
Ahmedabad 2
Arezzo 2
Ascoli Satriano 2
Bari 2
Bondeno 2
Dubai 2
Florence 2
Guangzhou 2
Kansas City 2
Kilburn 2
Lugo 2
Mumbai 2
Osogna 2
Parma 2
Romainville 2
Rome 2
Schio 2
Southwark 2
São Paulo 2
Taizhou 2
Tehran 2
Vazzola 2
Acton 1
Alfonsine 1
Ardabil 1
Baotou 1
Brno 1
Capannori 1
Cattolica 1
Chengdu 1
Chisinau 1
Chiswick 1
Cona 1
Dearborn 1
Dhaka 1
Easton 1
Edinburgh 1
Fuzhou 1
Haikou 1
Hangzhou 1
Hefei 1
Imola 1
Jinan 1
Totale 2.711
Nome #
Prospective identification of stent fracture by enhanced stent visualization system during percutaneous coronary intervention 133
Fractional flow reserve: Current applications and overview of the available data 130
Poor response to clopidogrel: current and future options for its management 130
Medical and interventional management of patients with severe thrombocytopenia undergoing percutaneous coronary intervention 128
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study) 127
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting 120
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 115
Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial 113
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 113
Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates 108
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study 105
Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry 105
Fractional flow reserve implementation in daily clinical practice: A European survey 102
Diagnostic performance of in-procedure angiography-derived quantitative flow reserve compared to pressure-derived fractional flow reserve: The FAVOR II Europe-Japan study 98
Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY) 97
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study 96
null 94
Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention? A Pre-Specified Analysis from the ZEUS Trial 89
Angina and left ventricular dysfunction: can we "reduce' it? 82
Thrombin generation assay: a new tool to predict and optimize clinical outcome in cardiovascular patients? 78
Cost-effectiveness of the coronary sinus Reducer and its impact on the healthcare burden of refractory angina patients 77
Seven french radial artery access for PCI: A prospective single-center experience 76
Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention: Relationship with gene polymorphisms and clinical outcome 70
Enhanced stent visualization systems during PCI: A case series and review of literature 68
Functional Assessment and Acute Coronary Syndrome 65
Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study 63
Prognostic Value of QFR Measured Immediately After Successful Stent Implantation: The International Multicenter Prospective HAWKEYE Study 63
Safety and Feasibility of Transradial Mini-Invasive Balloon Aortic Valvuloplasty: A Pilot Study 61
Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial. 57
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study 55
Angio-based index of microcirculatory resistance for the assessment of the coronary resistance: A proof of concept study 55
Contrast Associated Acute Kidney Injury and Mortality in Older Adults with Acute Coronary Syndrome: A Pooled Analysis of the FRASER and HULK Studies 53
Index of microcirculatory resistance assessment in patients with new diagnosis of left ventricular dilatation without significant coronary artery lesions: IMPAIRED pilot trial 52
Coronary Microvascular Dysfunction: PET, CMR and CT Assessment 49
10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction 49
Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study 47
Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials 44
One-Year Clinical Outcomes of Forty-Eight Millimeter Everolimus-Eluting Stent Implanted in Very Long Lesions: A Propensity-Matched Comparison (The FREIUS Study) 36
Safety, efficacy and impact on frailty of mini-invasive radial balloon aortic valvuloplasty 36
Lipid Plaque Burden in NSTE-ACS patients with or without COPD: insights from the SCAP trial 35
Angio-Based Fractional Flow Reserve, Functional Pattern of Coronary Artery Disease, and Prediction of Percutaneous Coronary Intervention Result: a Proof-of-Concept Study 32
Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients with ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial 29
Comparison of quantitative flow ratio, Pd/Pa and diastolic hyperemia-free ratio versus fractional flow reserve in non-culprit lesion of patients with non ST-segment elevation myocardial infarction 28
Effects of pre-hospital clopidogrel administration on early and late residual platelet reactivity in ST-segment elevation myocardial infarction patients undergoing primary intervention 25
Comment on [Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease] 23
Quantitative flow ratio as a new tool for angiography-based physiological evaluation of coronary artery disease: a review 21
Physiology-guided revascularization versus optimal medical therapy of nonculprit lesions in elderly patients with myocardial infarction: Rationale and design of the FIRE trial 20
Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over PrasugreL: a MUlticenter Randomized Open-label Trial in PatientS with ST-elevation Myocardial InFarction Referred for PrimAry PercutaneouS InTERvention (FABOLUS FASTER) Trial: Design and Rationale: The FABOLUS FASTER Trial 20
Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial 18
Bioresorbable vascular scaffold overlap evaluation with optical coherence tomography after implantation with or without enhanced stent visualization system (WOLFIE study): a two-centre prospective comparison 16
Acetylcholine Use in Modern Cardiac Catheterization Laboratories: A Systematic Review 14
Low FFR equal to low ischemia: Really? 14
Invasive Coronary Physiology After Stent Implantation: Another Step Toward Precision Medicine 14
Safety and efficacy of coronary sinus narrowing in chronic refractory angina: Insights from the RESOURCE study 9
Prospective validation of the bleeding academic research consortium classification in the all-comer PRODIGY trial 8
Angiographic control versus ischaemia-driven management of patients undergoing percutaneous revascularisation of the unprotected left main coronary artery with second-generation drug-eluting stents: rationale and design of the PULSE trial 7
Shedding Light on Treatment Options for Coronary Vasomotor Disorders: A Systematic Review 7
The unbearable lightness of the instantaneous wave-free ratio/fractional flow reserve discordance 6
Functional (Re)Development of SYNTAX Score II 2020: Predictive Performance and Risk Assessment 5
Totale 3.590
Categoria #
all - tutte 21.920
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.920


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020743 101 35 22 100 57 94 70 71 73 65 39 16
2020/2021553 28 29 28 59 16 33 25 80 31 90 87 47
2021/2022624 86 57 52 28 21 34 34 43 16 40 66 147
2022/2023471 59 23 36 27 74 62 25 49 66 6 32 12
2023/2024439 24 34 18 15 30 85 23 80 6 15 8 101
2024/202520 20 0 0 0 0 0 0 0 0 0 0 0
Totale 3.590